Top 5 Stocks to Buy Now
→ Trump’s Currency Coup Exposed (From Porter & Company) (Ad)tc pixel Free CDIOW Stock Alerts

Cardio Diagnostics (CDIOW) Competitors

Cardio Diagnostics logo
$0.02 0.00 (0.00%)
As of 06/24/2026 03:22 PM Eastern
Compare

CDIOW vs. SXTPW, DRTSW, APLMW, BIVIW, and CELUW

Should you buy Cardio Diagnostics stock or one of its competitors? MarketBeat compares Cardio Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardio Diagnostics include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does Cardio Diagnostics compare to 60 Degrees Pharmaceuticals?

Cardio Diagnostics (NASDAQ:CDIOW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

In the previous week, Cardio Diagnostics had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for Cardio Diagnostics and 1 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat Cardio Diagnostics' score of 1.43 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Cardio Diagnostics Positive
60 Degrees Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to Alpha Tau Medical?

Cardio Diagnostics (NASDAQ:CDIOW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

In the previous week, Alpha Tau Medical had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for Alpha Tau Medical and 2 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.43 beat Alpha Tau Medical's score of 0.96 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
Alpha Tau Medical Positive

Summary

Cardio Diagnostics beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does Cardio Diagnostics compare to Apollomics?

Cardio Diagnostics (NASDAQ:CDIOW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

In the previous week, Cardio Diagnostics and Cardio Diagnostics both had 2 articles in the media. Cardio Diagnostics' average media sentiment score of 1.43 beat Apollomics' score of 0.94 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
Apollomics Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Cardio Diagnostics and Apollomics tied by winning 1 of the 2 factors compared between the two stocks.

How does Cardio Diagnostics compare to BioVie?

Cardio Diagnostics (NASDAQ:CDIOW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, Cardio Diagnostics and Cardio Diagnostics both had 2 articles in the media. Cardio Diagnostics' average media sentiment score of 1.43 beat BioVie's score of 0.94 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
BioVie Positive

Summary

Cardio Diagnostics beats BioVie on 2 of the 2 factors compared between the two stocks.

How does Cardio Diagnostics compare to Celularity?

Cardio Diagnostics (NASDAQ:CDIOW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

In the previous week, Cardio Diagnostics and Cardio Diagnostics both had 2 articles in the media. Cardio Diagnostics' average media sentiment score of 1.43 beat Celularity's score of 0.30 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
Cardio Diagnostics Positive
Celularity Neutral

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Celularity N/A N/A N/A

Summary

Cardio Diagnostics and Celularity tied by winning 1 of the 2 factors compared between the two stocks.

Get Cardio Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDIOW vs. The Competition

Export
MetricCardio DiagnosticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$482.70M$6.61B$12.27B
Dividend YieldN/A3.86%2.67%5.89%
P/E RatioN/A3.1825.7623.97
Price / SalesN/A7,044.34553.2899.36
Price / CashN/A13.1346.3353.91
Price / BookN/A90.6210.706.32
Net IncomeN/A-$96.07M$3.57B$337.22M
7 Day PerformanceN/A1.86%0.79%-1.25%
1 Month PerformanceN/A0.64%0.22%-0.63%
1 Year PerformanceN/A71.08%30.84%27.95%

Cardio Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDIOW
Cardio Diagnostics
N/A$0.02
flat		N/A+29.6%$0.00$16.57KN/A7
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-7.1%		N/A-40.1%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$1.89
-3.1%		N/A+913.3%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
-10.3%		N/A-61.0%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.35
+12.9%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CDIOW) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX IPO “cancelled”?
SpaceX is approaching what could be a $1.6 trillion IPO - potentially the largest in history. But Louis Navell...
InvestorPlace | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
The EPA just put a kill switch on Elon’s empire
A federal EPA permit expires January 2, 2027 - and if Elon Musk's Colossus supercomputer loses power that day,...
Behind the Markets | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
Quick favor to ask you
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel